Please sign in so that we can notify you about a reply
Indications/Uses
Dissolution of cholesterol-rich gallstones in patients with functioning gallbladders; for the treatment of primary biliary cirrhosis.
Dosage/Direction for Use
Primary Biliary Cirrhosis (PBC): The recommended adult dosage in the treatment of PBC is 13-15 mg/kg/day administered in two to four divided doses with food. Dosing regimen should be adjusted according to each patient's need at the discretion of the physician.
Dissolution of Gallstone: The usual dose is 6-12 mg/kg/day either as a single night time dose or in divided doses. This may be increased to 15 mg/kg/day in obese patients, if necessary.
Dissolution of Gallstone: The usual dose is 6-12 mg/kg/day either as a single night time dose or in divided doses. This may be increased to 15 mg/kg/day in obese patients, if necessary.
Administration
Should be taken with food.
Contraindications
Known hypersensitivity or intolerance to Ursodeoxycholic acid or any of the components of the formulation.
Special Precautions
Patients with variceal bleeding, hepatic encephalopathy, ascites or in need of an urgent liver transplant, should receive appropriate specific treatment.
Use in Children: The safety and effectiveness of Ursodeoxycholic acid tablets in pediatric patients have not been established.
Use in Pregnancy: Safe use of administration during pregnancy has not been established, therefore, the drug should not be used in women who are or may become pregnant unless the potential benefits justify the possible risks to the fetus.
Use in Lactation: It is not known whether Ursodeoxycholic acid is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Ursodeoxycholic acid tablets are administered to a nursing mother.
Use in Children: The safety and effectiveness of Ursodeoxycholic acid tablets in pediatric patients have not been established.
Use in Pregnancy: Safe use of administration during pregnancy has not been established, therefore, the drug should not be used in women who are or may become pregnant unless the potential benefits justify the possible risks to the fetus.
Use in Lactation: It is not known whether Ursodeoxycholic acid is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Ursodeoxycholic acid tablets are administered to a nursing mother.
Use In Pregnancy & Lactation
Use in Pregnancy: Safe use of administration during pregnancy has not been established, therefore, the drug should not be used in women who are or may become pregnant unless the potential benefits justify the possible risks to the fetus.
Use in Lactation: It is not known whether Ursodeoxycholic acid is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Ursodeoxycholic acid tablets are administered to a nursing mother.
Use in Lactation: It is not known whether Ursodeoxycholic acid is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Ursodeoxycholic acid tablets are administered to a nursing mother.
Adverse Reactions
Abdominal discomfort & pain, constipation, diarrhea, dyspepsia, nausea, vomiting; pruritus, rash; resp disorders, general malaise, dizziness, calcified gallstones, increased liver enzymes, leukocytopenia & increase in serum bilirubin.
Drug Interactions
Bile Acid Sequestering Agents: Bile acid sequestering agents such as cholestyramine and colestipol may interfere with the action of Ursodeoxycholic acid tablet by reducing its absorption.
Aluminum-Based Antacids: Aluminum-based antacids have been shown to adsorb bile acids in vitro and may be expected to interfere with Ursodeoxycholic acid tablet in the same manner as the bile acid sequestering agents.
Drugs Affecting Lipid Metabolism: Estrogens, oral contraceptives, and clofibrate (and perhaps other lipid-lowering drugs) increase hepatic cholesterol secretion and encourage cholesterol gallstone formation and hence may counteract the effectiveness of Ursodeoxycholic acid tablet.
Aluminum-Based Antacids: Aluminum-based antacids have been shown to adsorb bile acids in vitro and may be expected to interfere with Ursodeoxycholic acid tablet in the same manner as the bile acid sequestering agents.
Drugs Affecting Lipid Metabolism: Estrogens, oral contraceptives, and clofibrate (and perhaps other lipid-lowering drugs) increase hepatic cholesterol secretion and encourage cholesterol gallstone formation and hence may counteract the effectiveness of Ursodeoxycholic acid tablet.
Storage
Store at temperatures not exceeding 25°C.
Action
Pharmacology: Pharmacodynamics: Mechanism of Action: Suppresses the synthesis and secretion of cholesterol by the live and inhibits intestinal absorption of cholesterol.
MedsGo Class
Cholagogues, Cholelitholytics & Hepatic Protectors
Features
Brand
Ursomax
Full Details
Dosage Strength
300mg
Drug Ingredients
- Ursodeoxycholic Acid
Drug Packaging
Tablet 1's
Generic Name
Ursodeoxycholic Acid
Dosage Form
Tablet
Registration Number
DR-XY42796
Drug Classification
Prescription Drug (RX)